Skip to main content
. 2024 Apr 3;628(8009):872–877. doi: 10.1038/s41586-024-07266-7

Fig. 4. MDE profiles (intention-to-treat population).

Fig. 4

MDEs, defined as the presence of exacerbated PA symptoms, the need for emergency care and evidence of biochemical abnormalities, were assessed 12 months before treatment and in the post-treatment period. Note that the definition of MDEs was updated during the study in response to discussions with regulatory agencies. MDEs that were reported by investigators before this update might not fully align with this current definition.